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Abstract
This review focuses on two questions: the role of mitochondria in excitotoxic neuronal death and the connection of
mitochondria with the apoptotic death cascade. The goal is to highlight the regulatory role of mitochondrial channels on the
mitochondrial membrane potential, vi, and their involvement in determining neuronal survival or death. A hypothesis is
developed centered on the notion that protein^protein interactions between members of the Bcl-2 family of death suppressor
and promoter proteins lead to the selective elimination of depolarizing currents that, in turn, collapse vi and set in motion
the irreversible pathway of cell death. The model considers the remarkable propensity of Bcl-2 family proteins to dimerize or
oligomerize and thereby restrict the localization of partner molecules to mitochondrial membrane contact sites. The
fundamental principle invoked here is that through a concerted set of protein^protein interactions, information is exchanged
by specific heterodimers, one of the partners acting as a toxic protein and the second as its antidote. The review concludes
with the elaboration of a speculative model about cellular mechanisms for the prevention of cell destruction as triggered by
extracellular signals which may be conserved in its molecular design from bacteria to eukaryotes. ß 1998 Elsevier Science
B.V. All rights reserved.
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1. Involvement of mitochondrial dysfunction in
excitotoxic neuronal death
A widely held view considers excitotoxic death, the
process by which prolonged activation of excitatory
neurotransmitter receptors leads to neuronal death,
as a pathogenic component in acute ischemic brain
injury, and in the development of chronic neurode-
generative disorders which are associated with neuro-
nal loss, such as Parkinson’s disease, Huntington’s
disease and Alzheimer’s dementia [1^5]. The under-
lying mechanisms for the selective vulnerability of
neurons are largely unknown. Glutamate receptors
of the N-methyl-D-aspartate (NMDA) subtype are
highly permeable to Ca2 and mediate its massive
in£ux leading to an imbalance of cellular homeosta-
sis and, in due turn, to cell death [6,7]. Collapse of
the mitochondrial vi with the ensuing drop of cel-
lular ATP, release of apoptosis inducing factors, pro-
duction of reactive oxygen species and NO, and ac-
tivation of numerous degradative enzymes are all
events intimately involved in the derangement of cel-
lular homeostasis triggered by unregulated glutamate
[1^5]. Indeed, blockers of the NMDA receptor pre-
vent excitotoxicity by arresting the cascade at the
departure point [8].
Mitochondria are unique among cell organelles in
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their involvement on the concerted consumption of
oxygen, production of oxygen radicals and mobiliza-
tion of intracellular Ca2 ([Ca2]i) [9^15]. Given that
excessive Ca2 accumulation in mitochondria uncou-
ples electron transfer from ATP synthesis and con-
sidering that impairment of energy metabolism in-
creases generation of free radicals [14^20],
mitochondria have emerged as the missing link be-
tween elevation of [Ca2]i and glutamate neurotox-
icity (Fig. 1) [21].
The critical role of mitochondria in excitotoxicity
has been recently documented primarily by examin-
ing the relationship between changes of [Ca2]i, mi-
tochondrial vi and neuronal cell death evoked by
glutamate agonists. For the sake of brevity, this as-
sessment is described following the pathway outlined
in Fig. 1 [21]. Prolonged stimulation of NMDA re-
ceptors in cultured hippocampal [19,21], cortical [20]
or cerebellar granule [15,22^26] neurons evokes a
massive accumulation of Ca2, which has been esti-
mated to reach an equivalent [Ca2]i of V20 mM
[27]. Persistent elevation of [Ca2]i, i.e. Ca2 over-
load, increases with the duration of the glutamate
agonist challenge. Concomitantly, the glutamate-in-
duced Ca2 overload produces neuronal death.
Time-lapse £uorescence imaging of the Ca2 indica-
tor Fluo-3 AM on hippocampal neurons identi¢ed a
disproportionately higher incidence of cell death than
anticipated from a tight correlation with the extent
of Ca2 overload [21]. Such disparity suggested that
additional steps intervene between elevation of
[Ca2]i and cell death. Similar results were obtained
by imaging cerebellar granule cells using Fura-2 AM
[15,22,23] and forebrain neurons by indo-1 micro-
£uorimetry [20].
The involvement of mitochondria was highlighted
by the enhanced susceptibility to NMDA-induced
Ca2 overload by antimycin A and rotenone, speci¢c
inhibitors of complex III and complex I of the elec-
tron transport chain. Signi¢cantly, antimycin A [21]
and cyanide, the speci¢c inhibitor of complex IV [28],
increase the susceptibility of hippocampal neurons to
NMDA-induced cell death, and complex I inhibitors
rotenone [29] and 1-methyl-4-phenylpyridinium [30]
enhanced the vulnerability of dopaminergic neurons
to NMDA-induced cell death. These results suggest a
model in which mitochondrial homeostasis acts as the
gatekeeper between cell survival and death (Fig. 1).
2. Excitotoxic neuronal death and the collapse of
mitochondrial membrane potential
The link between NMDA receptor overstimula-
tion, Ca2 sequestration, and impairment of mito-
chondrial function was strengthened by measure-
ments of mitochondrial vi during the excitotoxic
challenge using £uorescent potentiometric dyes (tet-
ramethylrhodamine ethyl ester-TMRE [21], rhod-
amine-123 [15,22^24], or JC-1 [20]. Glutamate ago-
nists induce prominent mitochondrial depolarization,
with a time scale coincident with the development of
Ca2 overload: increasingly longer NMDA stimuli
induce more conspicuous depolarizations, with de-
creasing extents of recovery establishing a linkage
between NMDA receptor overactivation and mito-
chondrial impairment. A tight association between
the incidence of neuronal cell death and mitochon-
drial damage as evidenced by the extent of mitochon-
drial depolarization was readily established, strength-
ening the connection between NMDA-induced Ca2
entry and collapse of vi (Fig. 1) [20,21,25,26].
It was surmised that the concurrent build-up of
intramitochondrial [Ca2] and attenuation of vi
might induce opening of the mitochondrial inner
membrane permeability transition pore (PTP), there-
by allowing £uxes of ions and small molecules and
collapsing vi [31^34] (Fig. 1). The PTP is the subject
of other reviews in this issue. Here we focus on the
speci¢c blockade of the PTP by the immunosuppres-
sant drug cyclosporin A (CsA) [12,33] which has
provided clues to implicate the PTP in excitotoxicity
[20,21,25]. If the PTP were a key entity in the cascade
leading to the Ca2 induced collapse of vi, it would
be anticipated that blocking the opening of the PTP
would promote the recovery of vi and would pre-
vent neuronal cell death. This prediction was ful-
¢lled. Quantitative analysis of results from a large
population of CsA exposed neurons showed that
the recovery of the mitochondrial depolarization is
practically complete, suggesting that the persistent
opening of the PTP underlies the collapse of vi
[21]. Remarkably, CsA protects neurons from gluta-
mate-induced death. These results implicate the PTP
in the collapse of vi elicited by prolonged activation
of the NMDA receptor and establish a connection
between mitochondrial dysfunction and excitotoxic
neuronal death [19^26,34^36] (Fig. 1).
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It is worthy of note that mitochondrial Ca2 entry
is only one of the factors known to trigger the PTP
[37]. Conspicuous among others are reactive oxygen
species and NO [34,38,39], considered key players in
the cascade of events leading to cell death. Further-
more, activation of the cytosolic phospholipase A2
(cPLA2) by Ca2 overload [40] is likely to release
arachidonic acid, an uncoupler of oxidative phos-
phorylation, with consequent mitochondrial swelling
and leakage of components out from the mito-
chondrial matrix [34]. Signi¢cantly, mice de¢cient
in cPLA2 exhibit reduced postischemic brain injury
[41]. In concert, these factors and others, may
contribute to the derangement of cellular homeosta-
sis that ultimately leads to neuronal cell death
(Fig. 1).
Fig. 1. Schematic representation of potential pathways by which mitochondrial dysfunction could act as an e¡ector of excitotoxic neu-
ronal death. Excessive activation of the NMDA receptor (NMDAR) induces massive Ca2 in£ux and abnormal elevations of [Ca2]i.
Mitochondrial Ca2 uptake, driven by vi, attenuates vi. This, in turn, causes a decrease in ATP synthesis and the opening of the
PTP, which collapses vi. Mitochondrial dysfunction elicits a further reduction in intracellular ATP pools, increases free radical gener-
ation, and most likely activates other processes that ultimately contribute to neuronal death (from [21]). Reproduced with permission.
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3. Connection with the apoptotic death cascade
Several pieces of information provide clues about
the association of the programmed cell death path-
way with excitotoxic neuronal death [1^4,26,31].
Conspicuously, the PTP-mediated collapse of vi is
abrogated by the anti-apoptotic protein Bcl-2
[31,32,34,42]. This raises the possibility that Bcl-2
may be a subunit of the PTP or a modulator of
the PTP. While Bcl-2 overexpression potentiates the
maximum Ca2 uptake in neurons and attenuates the
generation of reactive oxygen species [43], Bcl-2 de-
¢cient mice show substantial degeneration of periph-
eral sensory and sympathetic neurons as well as mo-
tor neurons [44]. By contrast, the archetypal pro-
apoptotic protein Bax is required for the death of
sympathetic neurons and motor neurons after troph-
ic factor deprivation [45]. Intriguingly, the Bcl-2 fam-
ily proteins appear to be localized at mitochondrial
membranes [46^48]. These ¢ndings, therefore, set mi-
tochondria at the crossroads of the death cascade.
What is known about the cascade and about the bio-
logical activities of these proteins?
4. Heterodimers in the death cascade
Signal transduction is the process by which an ex-
tracellular signal upon recognition by a speci¢c sur-
face receptor triggers a cascade of biochemical events
inside the cell that lead to immediate, and long-term
changes that ultimately determine the activity and
fate of the cell, including, but not limited to, growth,
di¡erentiation, survival or death. These cascades in-
volve complex networks of interacting molecules of
diverse size. The majority of these molecules are pro-
teins that act by presentation or by recognition of
surface determinants which lead to speci¢c interac-
tions between partner molecules. Interactions then
lead to the speci¢c actions of the involved partners,
frequently based on the interaction-induced confor-
mational changes. The newly produced surfaces, in
due turn, bring about new activities, for example,
uncovery or hindrance of enzymatic activity, and
creation or abrogation of a binding surface, or
even relocation of partner molecules between intra-
cellular compartments. Overall, these cascades exhib-
it the salient feature of ampli¢cation and are, there-
fore, involved in the regulation and control of critical
cellular pathways responsible for the maintenance of
cellular homeostasis. Any imbalance in these molec-
ular circuits can induce derangements, the speci¢city
and intensity of which may determine the ultimate
fate of the cell. These cascades are robust, meaning
that they display adaptation or the ability to resist
perturbations.
A case in point is the process of apoptosis. The
survival or death of a cell can be viewed as the ex-
pression of regulation, or dysregulation, by protein
conformational dynamics. A family of proteins
known as Bcl-2 proteins has been identi¢ed as key
controlling elements of the apoptotic cascade [49^53].
Fig. 2. Schematic representation of the information £ow in a
death cascade in which the signal relays are speci¢c hetero-
dimers, The contact sites between the inner (IM) and outer
(OM) mitochondrial membranes are displayed as the site of an-
choring or insertion of Bcl-2 family proteins. The + and 3
signs indicate the polarity of the mitochondrial membrane po-
tential vi. B2 and BX denote Bcl-2 and Bax proteins as proto-
types of death suppressor and promoter members of the family.
The coil protruding from the surface of BX represents the K2
helix that binds in a complementary cleft of Bcl-XL. A and C
represent Apaf-1 and Caspase 3, respectively (for review see
[74]).
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The family includes members which act as death sup-
pressors or anti-apopoptotic such as Bcl-2 (26 kDa)
and Bcl-XL (27 kDa), and death promoters or pro-
apoptotic, such as Bax (21 kDa), Bak, Bik and Bcl-
XS. Interactions between these two classes of pro-
teins frequently oppose their actions and their rela-
tive frequency of occurrence appears to modulate the
propensity of a cell to undergo apoptotic death [49^
53]. Multiple activities of these proteins have been
delineated and several targets recognized. Despite
the fact that the picture is still incomplete, a conspic-
uous characteristic of members of this family has
emerged: Bcl-2 proteins exhibit a strong propensity
to dimerize or oligomerize [49,50,54,55]. It is pre-
cisely this proclivity that may be at the root of their
intracellular activities.
Insights into the molecular basis for the function
of Bcl-2 proteins have emerged from the structure at
atomic resolution of Bcl-XL, an anti-apoptotic mem-
ber of the Bcl-2 family, and its complex with a pep-
tide derived from Bak, a proapoptotic protein. The
structures were obtained by X-ray crystallography
and NMR spectroscopy [56,57]. The recombinant
Bcl-XL protein used for the structural determination
did not include the transmembrane C-terminal an-
chor. The structure shows that Bcl-XL exhibits the
globin fold: seven helices form a compact globular
structure. The surface involved in dimerization has
been traced to a hydrophobic groove created by four
helices, namely K2, K4, K5 and K7. K2, also known as
the BH3 domain, has been recognized as a key com-
ponent in all death-promoting members of the Bcl-2
family, which are also devoid of K1, known to con-
tain the BH4 domain [58]. Remarkably, cleavage of
Bcl-2 by caspases releases the N-terminal fragment
that contains the BH4 domain (K1) and uncovers a
proapoptotic activity of Bcl-2 [59]. These considera-
tions suggest that an exposed K2 may be required to
promote death. The structure of a complex of Bcl-XL
and a 16-mer peptide patterned after the sequence of
Bak K2 was also determined. This peptide adopts an
amphiphilic helical structure that binds in the cleft of
Bcl-XL through hydrophobic and electrostatic inter-
actions. The structure of the complex indicates that
the molecular basis for the dimerization involves the
presentation on the surface of one partner of a com-
plementary amphipathic helix that ¢ts into the
groove of the second partner molecule. Complemen-
Table 1
Death cascade heterodimers
Key heterodimers Features
Bcl-2/Bax b Mitochondrial localization
b Control of vi
b Channel formation with multiple roles:
(a) release of cytochrome c, ATP, and other unidenti¢ed components
(b) release Apaf-1 from ternary complex
(c) attenuate or abolish the Bax-induced collapse of vi
(d) restoration of vi removes driving force for Bax insertion into the membrane
(e) exposure of K1 (BH4) facilitates interactions with other partners
b Redistribution between mitochondrial surface and cytosol in response to changes in vi or
vpH, and protein^protein interactions
Bcl-2/Apaf-1-(ADP) b Mitochondrial localization
b Anchoring of the zymogen caspase in the ternary complex
b Chaperonin-like function
Apaf-1-(ATP)/procaspase-3 b Nucleotide exchange (ADP/ATP) by chaperone Apaf-1-(ATP) releases the heterodimer
Apaf-1-procaspase from ternary complex with Bcl-2
b Hydrolysis of ATP allows processing of zymogen to active caspase-3
b Dissociation of Apaf-1-(ADP) from the heterodimer releases active caspase-3
Apaf-1-(ADP)/Bcl-2 b Apaf-1-(ADP) reassociates with Bcl-2 and relocates to mitochondria
b Heterodimer Apaf-1-(ADP)/Bcl-2 associates with procaspase into the ternary complex
b Cycle may be completed
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tarity is then the basis of speci¢city and would there-
fore determine the inclusion or exclusion of partners
in the heterodimer, as well as the stability of the
dimer. This is the basis for the model here presented.
5. Bcl-2 family members of death promoters and
suppressors are channel proteins: counterintuitive
or clue to mechanism?
The structure of Bcl-XL provided a result of great
impact towards the elucidation of the function of
Bcl-2 family proteins. The 3-D structure displays a
remarkable similarity to the pore forming domains of
diphtheria toxin (DT-fragment B) [60] and colicins
[61]. This similarity prompted several groups to ex-
amine the channel-forming activity of Bcl-2 family
proteins, and to investigate the transport through
the putative channels of elusive components of the
death cascade. Biophysical analysis of recombinant
Bcl-2 [62], Bcl-XL [63] and Bax [64,65], all devoid
of the C-terminal transmembrane anchor, showed
that they indeed form ion channels after reconstitu-
tion in lipid bilayers. The new ¢ndings have been
recently reviewed elsewhere [66], and here we focus
on the properties that may be relevant to their mode
of action in the death cascade.
The channel properties of each of these three pro-
teins di¡er from one another in terms of single chan-
nel conductance, selectivity, and voltage dependence.
However, they do show similarity with respect to DT
and colicins in so far as acid pH and negatively
charged lipids promote protein insertion and channel
formation [67,68]. From a mechanistic point of view,
all three Bcl-2 proteins form channels of heterogene-
ous conductances, consistent with the formation of
conductive oligomers with di¡erent stoichiometries,
and with the known propensity of these proteins to
form homodimers and heterodimers [49,50,54,55]. A
closer inspection of the 3-D structure indicates that
helices K5 and K6 are the likely candidates to insert
into the membrane. If a channel were formed by a
Bcl-2 homodimer and each subunit were to contrib-
ute a helical pair of K5 and K6, it follows that a four
helix bundle would be the structure underlying the
observed channel activity. In line with this reasoning
is the fact that a synthetic channel protein designed
to adopt a four helix bundle topology displays a
conductance of 20 pS, similar to the most frequent
conductance measured for Bcl-2 [69]. It is, therefore,
reassuring that a mutant Bcl-2 protein in which these
two helices were deleted is devoid of channel activity
[62]. In this context, sequence analysis shows that the
signature sequence for the Bcl-2 family of apoptosis
regulators is the amino-terminal half of K5 (consen-
sus NWGRIVALFAF) in which A is an identical
glutamate in human, rodent and murine Bcl-2 pro-
teins, and tyrosine in the corresponding Bax proteins.
The charged residues, R and E in Bcl-2 or R and Y
in Bax, are separated by seven residues, two turns of
helix apart. This locates them at the same face of the
helix, presumably exposed to the channel lumen
and in a key position to determine aspects of ionic
selectivity [62,69]. The strong conservation of this
signature sequence and its correspondence to a func-
tional module of this family of proteins suggests that
channel activity may be a clue to their cellular func-
tion(s).
It appears as counterintuitive to consider a chan-
nel forming protein localized to mitochondrial
membranes as a death suppressor. After all, grami-
cidin, one of the best studied channel-forming pep-
tides, is an uncoupler of oxidative phosphorylation
[70]. It is more congruent to think of a death pro-
moter as a channel former because a plethora of
reports indicate that cell death is readily inducible
by forming pores in cell membranes, from bacteria
to eukaryotes [71]. This discrepancy may be resolved
by considering the fact that pro- and anti-apoptotic
proteins heterodimerize and that elimination of the
death-promoter by the death-suppressor through di-
merization may be at the core of this regulatory
process [49,50,54,55]. Furthermore, if vi were in-
volved in determining the activity of the hetero-
dimers, as surmised from the voltage dependence
for channel formation by Bcl-2 family proteins,
then a plausible sequence of events that connect the
mitochondria with these proteins may be envisioned:
changes in vi would promote the association of Bcl-
2 and Bax and restrict them to the mitochondrial
surface. Dimer formation would promote dissocia-
tion of other entities of the death cascade from
Bcl-2 and allow them to di¡use into the cytosol
where these could interact with downstream compo-
nents of the cascade. CsA, acting via a mitochon-
drial cyclophilin, may function as neuroprotectant
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[20,21,25] by changing the protein^protein interact-
ing surfaces of the partners. This model connects a
mitochondrial membrane transport and anchoring
activity with the regulation of the death cascade. Is
there any evidence for such a scheme?
Analysis of gene products involved in the death
cascade of the nematode Caenorhabditis elegans
(cell death or CED genes) disclosed three classes of
proteins involved in the process: CED-9, CED-4 and
CED-3 (for review see [72,73]). The corresponding
mammalian homologs have been identi¢ed and they
are hereafter denoted as Bcl-2 family, Apaf-family
(for apoptosis protease activating factors) and Cas-
pase family (for cysteine-dependent, aspartate-specif-
ic protease), respectively (for review see [74]). The
three families could be visualized as three independ-
ent, yet interacting modules and denoted as B, A,
and C for Bcl-2, Apaf and Caspase families, respec-
tively (Fig. 2). Numerous members for each of these
sets of proteins have been identi¢ed and it is likely
that more will emerge. The interactions between
these proteins are beginning to be delineated and,
therefore, a minimum sequence of events that may
lead to cell death may be heuristically formulated.
For simplicity, two states are described, a quiescent
state associated with ‘life’ and the ¢nal state of the
pathway-‘death’, and only a single prototype mem-
ber of each family is selected. The model considers
that the ternary complex BAC is stable in the quies-
cent state and that heterodimers are the functional
information exchangers. Some speci¢c features of the
individual protein products provide constraints to
the model and these are listed in the form of ‘key
heterodimers’ in Table 1.
The starting point of the model is the quiescent
state in which the ternary complex is stabilized by
the ADP-form of Apaf-1 (A) [75^79] and is anchored
via the C-terminal transmembrane domain of Bcl-2
(B2) to the mitochondrial outer membrane at the so-
called zone of adhesion or ZOA, where the outer and
inner mitochondrial membranes make contact [46^
48]. In such state, the zymogen caspase (C) would
be inactive.
5.1. Events at the mitochondrial surface
The signal cascade considers that a death stimulus
will funnel into a change of mitochondrial vi. Spe-
ci¢cally, for excitotoxicity this could arise from glu-
tamate-induced elevation of [Ca2]i, production of
free oxygen radicals and NO, ATP depletion or com-
binations thereof. All these events may lead the
opening of the PTP. Attenuation of vi would pro-
mote insertion of Bax (BX, Fig. 2) into the mito-
chondrial membrane which would further collapse
vi ; this is consistent with the voltage dependence
for channel formation by Bax in lipid bilayers
[64,65], and with the redistribution of cytosolic Bax
to mitochondria during apoptosis [48]. This, in turn,
may induce mitochondrial swelling and consequent
release of cytochrome c [80^82] (also denoted as
Apaf-2), other mitochondrial matrix enzymes [83]
and ATP which may be required for caspase activa-
tion [75^84]. That the Bax channel provides the con-
duit through which cytochrome c is released from the
intermembrane space to the cytosol has been consid-
ered [51,85], and that Bcl-XL inhibits the collapse of
vi and the release of cytochrome c has been re-
ported [86]. Perhaps, the protective actions of Bcl-
XL [86] and Bcl-2 [80^82] arise from heterodimeriza-
tion with Bax. The presumably higher a⁄nity of Bcl-
2 for Bax mediated by the K2 helix may promote
heterodimerization with Bax (B2/BX, Fig. 2). Indeed,
peptides with sequences patterned after the BH3 re-
gion of Bak and Bax and corresponding to K2 of Bcl-
XL are inhibitors of homodimer and heterodimer
formation by Bcl-2 family members [87]. The propen-
sity to form the Bcl-2/Bax binary complex, assisted
by the released ATP which may facilitate ADP for
ATP nucleotide exchange at the Apaf-1, may induce
dissociation of the Apaf-1-(ATP)/zymogen complex
(AC, Fig. 2).
5.2. Events in the cytosol
The released Apaf-1-(ATP)/zymogen heterodimer
with the chaperone in the ATP form (AC-ATP)
may allow processing of the zymogen to yield the
active caspase [75^79]. This processing reaction may
require ATP hydrolysis which may change the con-
formation of Apaf-1-(ADP) and facilitate its dissoci-
ation from the binary complex. Cytochrome c re-
leased from swollen mitochondria is also an
activator of caspase 3 (CPP32) [77,80^82]. Apaf-1-
(ADP) monomer may associate to Bcl-2 and free
zymogen caspase to regenerate the heterotrimer and
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thereby complete the cycle. Moreover, it was recently
revealed that Bcl-2 is a caspase 3 (CED-3) protease
inhibitor [88], thereby introducing another unsus-
pected role for monomeric Bcl-2 in the cascade,
and that monomeric Bax in non-apoptotic cells is a
soluble protein di¡usely distributed throughout the
cytosol [48]. Furthermore, Apaf-3 is caspase-9 which
requires cytochrome c and ATP to become active
[84].
The fundamental principle invoked here is that
through a concerted set of protein^protein interac-
tions, information is exchanged by speci¢c hetero-
dimers, one of the partners acting as a toxic protein
and the second as its antidote. For the Bax/Bcl-2
heterodimer, Bax is known to collapse vi and per-
haps provide the conduit for cytochrome c to exit
from mitochondria into cytosol where it activates
caspase 3; Bcl-2 allows recovery of vi, inhibits re-
lease of caspase activating factors, including cyto-
chrome c and prevents cell death. The presumed
chaperonin activity of Apaf-1 allows it to act as an
adaptor protein: in its ADP-form, it mediates the
stability of ternary complex with Bcl-2 and the zym-
ogen caspase; in its ATP form, it allows both the
dissociation from Bcl-2 and the processing of the
zymogen into an active caspase, implicated in the
ultimate demise of the cell.
The physiological role of the B, A and C modules
in vivo may be inferred from studies with transgenic
mice, either by overexpression of the gene product or
by gene ablation. For the B module, overexpression
studies have clearly shown that Bcl-2 and Bcl-XL act
as neuronal survival factors in developmental para-
digms, growth factor deprivation or ischemic insults
(for review see [50,89^91]). Mice de¢cient in Bcl-2 do
not show gross brain changes presumably resulting
from functional redundancy, yet cerebellar granule
neurons exhibit increased suceptibility to cell death
[92], and motor and sensory neurons to degeneration
during development [44]. Bax-de¢cient mice, how-
ever, show increase in neuron number in the superior
cervical ganglia and increased protection of sympa-
thetic neurons from cell death induced by nerve
growth factor-withdrawal [45]. No information is
yet available from gene ablation studies of the
Apaf family. For the C module, mice de¢cient in
the CED-3 related protease CPP32 show drastic al-
terations in brain development and markedly attenu-
ated apoptosis in brain regions associated with major
morphogenetic change during normal development
[93]. Further, glutamate-induced apoptosis of cere-
bellar granule neurons involves activation of cas-
pase-3 protease [94].
5.3. Modulation by protein phosphorylation
Phosphorylation on serine/threonine of Bcl-2 at-
tenuates its anti-apoptotic activity whereas phos-
phorylation of Bad blocks its pro-apopoptotic activ-
ity, presumably by hindering dimerization. The Raf-1
kinase [95] as well as calcineurin, a phosphatase [96],
bind to Bcl-2 via the K1 helix and get translocated
from the cytosol to the mitochondrial surface. Het-
erodimerization of Bcl-2 with Bax suppresses com-
plex formation with calcineurin [96]. Phosphoryla-
tion of the pro-apoptotic protein Bad by the serine/
threonine protein kinase Akt [97] and by Raf-1 [95]
releases it from Bcl-XL at the mitochondrial surface
and allows association of Bad with 14-3-3 restricting
it to the cytosol. Dissociation of Bcl-XL presumably
allows it to resume its antiapoptotic activity via its
interactions with either the downstream components
of the caspase cascade, or its partners by relocating
at the mitochondrial membrane. Noteworthy, Akt-
mediated phosphorylation of Bad suppresses Bad-in-
duced cell death in cerebellar granule neurons
[97,98], and Bcl-2 blocks calcium-activated cell death
produced by overexpression of calcineurin [99]. The
selective recognition of kinases and phosphatases by
the same domain of Bcl-2 (K1 or BH4), which is
absent in many of the death promoters, implies
that the resulting interactions may be essential for
the regulation of cell survival. Notably, removal of
K1 from Bcl-2 transforms it from a death suppressor
to a death promoter [59].
6. Toxin-antidote bimodular design for the control
of cell destruction
The notion that a programmed death cascade con-
stitutes a selective mechanism to avoid random self-
destruction [100,101] implies that the fundamental
design of the molecular machinery destined for this
function may be conserved in evolution. Apoptosis
has been identi¢ed among several unicellular eukar-
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yotes, remarkably the earliest mitochondrial eukar-
yotes such as Trypanosoma cruzi [102], Trypanosoma
brucei rhodensiense [103], Tetrahymena thermophila
[104], and Dicyostellium discoideum [105] (for review
see [100]).
The occurrence of programmed self-destruction in
prokaryotes has been inferred from considerations
that moribund or starving populations undergo bac-
teriolysis as an ‘altruistic’ means to reduce competi-
tion for nutrients or to provide cellular contents for
the support of the surviving cells [100]. Plasmid ad-
diction modules, consisting of a toxin/antidote gene
pair, are implicated in the programmed death of
starving bacteria [101]. From this viewpoint, self-de-
struction is tightly coupled to survival and if the
ratio of toxin to antidote is overpowering, death en-
sues. Plasmid addiction modules may encode restric-
tion endonucleases and their cognate methylases, in
which the latter (as antidote) modi¢es DNA to pre-
vent the action of the restriction enzyme (the toxin).
The diversity of the toxins and antidotes is broad. In
the context of this review, it is pertinent to emphasize
that the toxins include members of the colicin E1
family which are bacteriolytic by forming channels
in target cells. gef and hok (for host killing) are intra-
cellular toxins which are cytolytic by dissipating the
membrane potential, presumably through the forma-
tion of ionic channels [106,107]. The antidote in this
pair, e.g. sok (for suppression of killing) consists of
antisense RNA bound to a precursor of the mRNA
that encodes the toxin and thereby blocks its syn-
thesis [108,109]. In Escherichia coli, the entericidin
locus encodes two lipoproteins that may constitute
another example of toxin/antidote gene pair: enter-
icidin A is an antidote to the bacteriolytic entericidin
B (Bishop, Leskiw, Hodges, Kay and Weiner, The
entericidin locus of E. coli and its implications for
programmed bacterial cell death, J. Mol. Biol. (1998)
in press). Both proteins contain a lipoprotein proc-
essing site that would yield peptides of 23 and 26
amino acids, respectively. Synthetic peptides pat-
terned after the corresponding sequences form am-
phipathic K-helices and exhibit a high propensity to
form coiled-coils. As the entericidin AB pair, the
coiled-coil of two amphipathic helices would provide
a stable, yet inert entity. Individually, enterocidin B
exhibits the hallmark characteristics of a channel-
forming peptide that would insert into membranes
and self-assemble into conductive oligomers [69]. In
contrast, entericidin A, has features that would con-
strain it at the membrane interface restricting its in-
sertion into the bilayer core [110]. Then, again, the
AB pair may represent an e⁄cacious design to sup-
press or unleash the channel activity of entericidin B
and, therefore, control cell death.
A fascinating example of the toxin/antidote bi-
modular strategy adapted for the control of survival
or death may be found in the family of peptides
called defensins [111]. Defensins are small (V30-
mer) cationic peptides which exhibit cytotoxic and
antimicrobial activity. The 3-dimensional structure
of several members of the family has been solved
by X-ray crystallography and NMR spectroscopy
[112]. The fold of the monomer is conserved and
consists of a triple stranded antiparallel L-sheet
with a framework of six disul¢de-linked cysteines.
The cytolytic entity is presumably an oligomer of
six dimers organized around a central aqueous pore
[111]. It is surmised that a ¢rst step in killing is the
binding of cationic defensins to acidic phosphatidyl-
serine in the inner lea£et of the membrane bilayer;
this is followed by a voltage-dependent insertion into
the bilayer core and assembly of the transmembrane
pore [111,112]. Human defensins, also known as hu-
man neutrophil peptides (HNP1^3), are synthesized
as a 94 amino acid proprecursor which is post-trans-
lationally proteolyzed to inactive proHNP(20^94)
[113]. This precursor consists of an N-terminal seg-
ment called the ‘anionic propiece’ which, in turn, is
cleaved o¡ to release the mature defensin HNP-1 and
HNP-3(65^94) or HNP-2(66^94). In neutrophils, the
mature defensins are stored in secretory granules.
Remarkably, both modules are amphiphilic, and
the ‘anionic propiece’ is an intramolecular inhibitor
of the ‘cationic defensin’ cytotoxic activity [113].
Again, this suggests the occurrence of a toxin/anti-
dote pair. The anionic propiece may act not only as
an inhibitor, but also function as structural stabilizer
^ a chaperonin-like activity, or assist in membrane
targeting. In other cellular systems or contexts, the
two modules may act as independent molecules, as
inferred from the occurrence of insect defensins, V4
kDa peptides from Drosophila [114] and scorpion
[115]. Insect defensins conspicuously kill Micrococcus
luteus by forming voltage-dependent pores which col-
lapse the cell membrane potential [116].
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Is it then conceivable that Bcl-2 proteins also con-
stitute a toxin/antidote pair with the inherent combi-
natorial diversity that may arise from the plethora of
family members operating as death promoters (toxin)
or suppressors (antidote)?
7. Concluding remarks
An attempt was made to integrate evidence impli-
cating mitochondrial channels in the death cascade.
A plausible connection posits the notion that death
signals (e.g. glutamate-induced Ca2 overload in neu-
rotoxicity) funneled via changes in mitochondrial vi
(Fig. 1) selectively dysregulate a ‘toxin^antidote’ pair
formed by death promoter/death suppressor mem-
bers of the Bcl-2 family (Fig. 2). This in turn, would
unleash an avalanche of events that lead to the im-
minent demise of the cell. Until more is known about
the components of the cascade and their interactions
than is known at present, it will be di⁄cult to discern
the key controlling steps in the network. With access
to the wealth of sequence information from complete
genomes of archaea (M. jannaschii), eubacteria (E.
coli) as well eukaryotic (Saccharomyces cerevisiae)
organisms (cf. [117]), the prospect of deciphering
the connectivity between the components of the
death cascade and understanding this fundamental
process is an exciting challenge.
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